Our employees

Jakob Knudsen
Chief Executive Officer
jk@virogates.com

Mark da Silva
Chief Financial Officer
mds@virogates.com

Jesper Eugen-Olsen
Chief Scientific Officer
jeo@virogates.com

Thomas Krarup
VP Global Sales & Marketing
tkr@virogates.com

May Britt Dyvelkov
VP of Accounting
mbd@virogates.com

David Stig Wülser
Head of Marketing
dsw@virogates.com

Jérôme Bouffel
Country Manager France & Benelux
jeb@virogates.com

Julio Ajenjo
Sales Manager Spain
jag@virogates.com

Nicolaj Toutain
Marketing Assistant
nto@virogates.com

Sonia Katarzyna Flendrich
Marketing Assistant
skf@virogates.com

Alina Liliana Vlaicu
Marketing Assistant
alv@virogates.com

Want to learn more about ViroGates?

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates